Reaction Details  Report a problem with these data
Target
Glucagon-like peptide 1 receptor
Ligand
BDBM50007215
Substrate
n/a
Meas. Tech.
ChEMBL_1338730 (CHEMBL3242201)
IC50
>10000±n/a nM
Citation
 DeMong, D; Dai, X; Hwa, J; Miller, M; Lin, SI; Kang, L; Stamford, A; Greenlee, W; Yu, W; Wong, M; Lavey, B; Kozlowski, J; Zhou, G; Yang, DY; Patel, B; Soriano, A; Zhai, Y; Sondey, C; Zhang, H; Lachowicz, J; Grotz, D; Cox, K; Morrison, R; Andreani, T; Cao, Y; Liang, M; Meng, T; McNamara, P; Wong, J; Bradley, P; Feng, KI; Belani, J; Chen, P; Dai, P; Gauuan, J; Lin, P; Zhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem 57:2601-10 (2014) [PubMed]  Article
Target
Name:
Glucagon-like peptide 1 receptor
Synonyms:
GLP-1 receptor | GLP-1-R | GLP-1R | GLP1R | GLP1R_HUMAN | Glucagon-like peptide 1 receptor | Glucagon-like peptide 1 receptor (GLP-1)
Type:
Enzyme
Mol. Mass.:
53035.78
Organism:
Homo sapiens (Human)
Description:
P43220
Residue:
463
Sequence:
MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS
  
Inhibitor
Name:
BDBM50007215
Synonyms:
CHEMBL3237927
Type:
Small organic molecule
Emp. Form.:
C32H39Cl2N7O2
Mol. Mass.:
624.604
SMILES:
CC(C)C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:13.17,4.3,wD:10.11,c:8,(6.83,-40.7,;8.15,-39.91,;9.5,-40.66,;8.13,-38.37,;9.46,-37.59,;9.4,-36.05,;10.62,-35.1,;12.09,-35.51,;10.08,-33.65,;8.54,-33.71,;8.12,-35.19,;6.94,-34.2,;5.49,-34.74,;5.23,-36.25,;6.41,-37.24,;7.86,-36.71,;3.79,-36.79,;2.6,-35.8,;2.34,-37.32,;3.53,-38.3,;10.86,-32.32,;10.1,-30.99,;10.87,-29.66,;10.11,-28.32,;12.42,-29.66,;13.18,-31,;14.72,-31.01,;12.4,-32.33,;10.78,-38.37,;10.76,-39.92,;12.09,-40.7,;13.43,-39.95,;13.45,-38.41,;12.13,-37.62,;14.76,-40.74,;14.74,-42.28,;16.1,-39.99,;17.42,-40.77,;18.76,-40.02,;20.16,-40.65,;21.2,-39.52,;20.45,-38.18,;18.94,-38.48,)|
Structure:
Search PDB for entries with ligand similarity: